Literature DB >> 34321013

Identification of uterine leiomyosarcoma-associated hub genes and immune cell infiltration pattern using weighted co-expression network analysis and CIBERSORT algorithm.

Xiaoqing Shen1, Zhujuan Yang1, Songwei Feng1, Yi Li2.   

Abstract

BACKGROUND: While large-scale genomic analyses symbolize a precious attempt to decipher the molecular foundation of uterine leiomyosarcoma (ULMS), bioinformatics results associated with the occurrence of ULMS based totally on WGCNA and CIBERSORT have not yet been reported. This study aimed to screen the hub genes and the immune cell infiltration pattern in ULMS by bioinformatics methods.
METHODS: Firstly, the GSE67463 dataset, including 25 ULMS tissues and 29 normal myometrium (NL) tissues, was downloaded from the public database. The differentially expressed genes (DEGs) were screened by the 'limma' package and hub modules were identified by weighted gene co-expression network analysis (WGCNA). Subsequently, gene function annotations were performed to investigate the biological role of the genes from the intersection of two groups (hub module and DEGs). The above genes were calculated in the protein-protein interaction (PPI) network to select the hub genes further. The hub genes were validated using external data (GSE764 and GSE68295). In addition, the differential immune cell infiltration between UL and ULMS tissues was investigated using the CIBERSORT algorithm. Finally, we used western blot to preliminarily detect the hub genes in cell lines.
RESULTS: WGCNA analysis revealed a green-yellow module possessed the highest correlation with ULMS, including 1063 genes. A total of 172 DEGs were selected by thresholds set in the 'limma' package. The above two groups of genes were intersected to obtain 72 genes for functional annotation analysis. Interestingly, it indicated that 72 genes were mainly involved in immune processes and the Neddylation pathway. We found a higher infiltration of five types of cells (memory B cells, M0-type macrophages, mast cells activated, M1-type macrophages, and T cells follicular helper) in ULMS tissues than NL tissues, while the infiltration of two types of cells (NK cells activated and mast cells resting) was lower than in NL tissues. In addition, a total of five genes (KDR, CCL21, SELP, DPT, and DCN) were identified as the hub genes. Internal and external validation demonstrated that the five genes were over-expressed in NL tissues compared with USML tissues. Finally, the correlation analysis results indicate that NK cells activated and mast cells activated positively correlated with the hub genes. However, M1-type macrophages had a negative correlation with the hub genes. Moreover, only the DCN may be associated with the Neddylation pathway.
CONCLUSION: A series of evidence confirm that the five hub genes and the infiltration of seven types of immune cells are related to USML occurrence. These hub genes may affect the occurrence of USML through immune-related and Neddylation pathways, providing molecular evidence for the treatment of USML in the future.
© 2021. The Author(s).

Entities:  

Keywords:  CIBERSORT; Neddylation; Uterine leiomyosarcoma; Weighted co-expression network

Mesh:

Year:  2021        PMID: 34321013     DOI: 10.1186/s12957-021-02333-z

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  36 in total

Review 1.  Management of uterine leiomyosarcoma.

Authors:  Marcin Bobiński; Janusz Jacek Kraczkowski; Elżbieta Witt; Iwona Wertel; Grzegorz Polak; Jan Kotarski; Wiesława Bednarek
Journal:  Wiad Lek       Date:  2016

Review 2.  Immunotherapy in ovarian cancer.

Authors:  K Odunsi
Journal:  Ann Oncol       Date:  2017-11-01       Impact factor: 32.976

Review 3.  Molecular targeted therapy: Treating cancer with specificity.

Authors:  Yeuan Ting Lee; Yi Jer Tan; Chern Ein Oon
Journal:  Eur J Pharmacol       Date:  2018-07-20       Impact factor: 4.432

Review 4.  Lung cancer: current therapies and new targeted treatments.

Authors:  Fred R Hirsch; Giorgio V Scagliotti; James L Mulshine; Regina Kwon; Walter J Curran; Yi-Long Wu; Luis Paz-Ares
Journal:  Lancet       Date:  2016-08-27       Impact factor: 79.321

Review 5.  Uterine leiomyosarcoma: A review of the literature and update on management options.

Authors:  Maureen E Roberts; Jason T Aynardi; Christina S Chu
Journal:  Gynecol Oncol       Date:  2018-09-21       Impact factor: 5.482

Review 6.  Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome.

Authors:  R R Cui; J D Wright; J Y Hou
Journal:  BJOG       Date:  2017-04-01       Impact factor: 6.531

Review 7.  Treatment of early uterine sarcomas: disentangling adjuvant modalities.

Authors:  Flora Zagouri; Athanasios-Meletios Dimopoulos; Stelios Fotiou; Vassilios Kouloulias; Christos A Papadimitriou
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754

8.  Is revisional surgery mandatory when an unexpected sarcoma diagnosis is made following primary surgery?

Authors:  Georgios Koulaxouzidis; Eugenia Schwarzkopf; Holger Bannasch; G Björn Stark
Journal:  World J Surg Oncol       Date:  2015-10-24       Impact factor: 2.754

9.  The biology of uterine sarcomas: A review and update.

Authors:  Hiroshi Kobayashi; Chiaki Uekuri; Juria Akasaka; Fuminori Ito; Aiko Shigemitsu; Natsuki Koike; Hiroshi Shigetomi
Journal:  Mol Clin Oncol       Date:  2013-05-20

10.  Surgical results of pelvic exenteration in the treatment of gynecologic cancer.

Authors:  Andrea Petruzziello; William Kondo; Sergio B Hatschback; João A Guerreiro; Flávio Panegalli Filho; Cristiano Vendrame; Murilo Luz; Reitan Ribeiro
Journal:  World J Surg Oncol       Date:  2014-09-08       Impact factor: 2.754

View more
  6 in total

1.  Identification of Immune-Related Genes for Risk Stratification in Multiple Myeloma Based on Whole Bone Marrow Gene Expression Profiling.

Authors:  Qiang-Sheng Wang; Qi-Qin Shi; Ye Meng; Meng-Ping Chen; Jian Hou
Journal:  Front Genet       Date:  2022-05-26       Impact factor: 4.772

2.  Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy.

Authors:  Qingquan Zhang; Mengkang Fan; Xueyan Cao; Haihua Geng; Yamin Su; Chunyu Wu; Haiyan Pan; Min Pan
Journal:  Front Cardiovasc Med       Date:  2022-04-01

3.  Integrative Analysis From Multicenter Studies Identifies a WGCNA-Derived Cancer-Associated Fibroblast Signature for Ovarian Cancer.

Authors:  Songwei Feng; Yi Xu; Zhu Dai; Han Yin; Ke Zhang; Yang Shen
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

4.  m6A-Related lncRNA Signature Is Involved in Immunosuppression and Predicts the Patient Prognosis of the Age-Associated Ovarian Cancer.

Authors:  Ming Li; Liang Zhang; Miaoxiao Feng; Xiao Huang
Journal:  J Immunol Res       Date:  2022-08-10       Impact factor: 4.493

5.  Comprehensive Analysis of LINC01615 in Head and Neck Squamous Cell Carcinoma: A Hub Biomarker Identified by Machine Learning and Experimental Validation.

Authors:  Xiaoyan Yin; Jingmiao Wang; Yanrui Bian; Qiaojing Jia; Ziyi Shen; Haizhong Zhang
Journal:  J Oncol       Date:  2022-06-27       Impact factor: 4.501

6.  Integrated Bioinformatics Analysis Identifies Robust Biomarkers and Its Correlation With Immune Microenvironment in Nonalcoholic Fatty Liver Disease.

Authors:  Feng Zhang; Zhengwei Zhang; Yapeng Li; Yi Sun; Xinliang Zhou; Xiaoning Chen; Shibo Sun
Journal:  Front Genet       Date:  2022-07-14       Impact factor: 4.772

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.